Total buying$00 buys
CHE
CHEMED CORP
NYSEHealthcareServices-Home Health Care Services
Insider activity for last month from 09/19 to 10/19.
How these metrics are calculated
Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total selling$1.02M1 sells
Net open-market−$1.02MBuying minus selling
Active insiders3Distinct reporting owners
Insider activity report
Calendar-month buckets within the selected date range
Latest filing: Oct 01, 2026
Open-market transaction mix · 1 transactions in the selected period
Code A includes awards, grants and other acquisitions; these are not open-market buys. A rolling period can include partial calendar months.
View exact monthly counts and disclosed values
| Month | Buys | Sells | Awards (A) | Buy value | Sell value | Net P/S value |
|---|---|---|---|---|---|---|
| Sep 2026 | 0 | 1 | 0 | $0 | $1.02M | -$1.02M |
| Oct 2026 | 0 | 0 | 0 | $0 | $0 | $0 |
Distinct insiders active
Reporting-owner CIKs by month · peak Sep 2026 (3)Sep 2026Oct 2026
Largest insider activity
By absolute net disclosed value · current transaction page- LS-$5.7M
- HC-$2.2M
- MJ-$1.0M
CHE transaction history
Newest filings · 20 transactions per pageLatest insider transactions
Form 4 filings from last month.| Company | Insider | Activity | Disclosed value | Filed (ET) |
|---|---|---|---|---|
CHECHEMED CORP | Lee Spencer SEVP | M · exerciseDerivative securitySEC filing ↗ | -$5.38MView disclosure → | |
CHECHEMED CORP | Lee Spencer SEVP | F · withholdingSEC filing ↗ | -$5.67MView disclosure → | |
CHECHEMED CORP | Lee Spencer SEVP | M · exerciseSEC filing ↗ | $5.38MView disclosure → | |
CHECHEMED CORP | Mcnamara Kevin JPRES | S · saleSEC filing ↗ | -$1.02MView disclosure → | |
CHECHEMED CORP | Hutton Thomas CVP | M · exerciseDerivative securitySEC filing ↗ | -$2.06MView disclosure → | |
CHECHEMED CORP | Hutton Thomas CVP | F · withholdingSEC filing ↗ | -$2.16MView disclosure → | |
CHECHEMED CORP | Hutton Thomas CVP | M · exerciseSEC filing ↗ | $2.06MView disclosure → |
Filing-only signals
Deterministic matches in the selected period
Filing detail checks
Secondary metrics for the selected periodTransaction codes
By Form 4 transaction code in selected period7transactionstxns
- M · Option exercise · dominant4 · 57%
- F · Tax withholding2 · 29%
- S · Open-market sells1 · 14%
Activity by reported role
A joint filing can contribute to multiple rolesEVP3
VP3
PRES1
Reported Holdings After
Separated by insider, security, and ownership type
Hutton Thomas CCapital Stock · Direct
32,840Sep 28, 2026
Lee Spencer SCapital Stock · Direct
14,851Sep 30, 2026
Hutton Thomas CStock Option (right to buy with tandem tax withholding) · Direct
22,089Sep 28, 2026
Mcnamara Kevin JCapital Stock · Direct
66,418Sep 28, 2026
Lee Spencer SStock Option (right to buy with tandem tax withholding) · Direct
16,097Sep 30, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Current transaction page only · each cell is a filing date · buys green, sells redSep 19 → Oct 19
LessMore
CHEMED CORP Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at CHEMED CORP?
LEE SPENCER S, MCNAMARA KEVIN J, HUTTON THOMAS C.
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
Mcnamara Kevin J reported a sale on Sep 28, 2026 valued at $1.02M. Read the SEC filing.
What is the recent purchase and sale balance?
Net open-market selling in the selected period was $1,026,900.00. Sales can occur for many non-investment reasons.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.